Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Baxter
Citi
Colorcon
Johnson and Johnson
Fuji
Chinese Patent Office
Accenture
Queensland Health
Moodys

Generated: December 16, 2018

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR PALIPERIDONE

« Back to Dashboard

Clinical Trials for Paliperidone

Trial ID Title Status Sponsor Phase Summary
NCT00073320 Intramuscular Injections of Paliperidone Palmitate in the Arm or Buttock of Subjects With Schizophrenia Completed Johnson & Johnson Pharmaceutical Research & Development, L.L.C. Phase 3 The purpose of the study is to compare the pharmacokinetic parameters (blood concentrations) of i.m. paliperidone palmitate after administration in 2 different injection sites (deltoid or gluteal).
NCT00074477 Safety and Efficacy of an Anti-Psychotic in Patients With Schizophrenia Completed Johnson & Johnson Pharmaceutical Research & Development, L.L.C. Phase 2 The purpose of this study is to determine the efficacy (how well the drug works), safety, and side effects of paliperidone palmitate injection compared to placebo in the treatment of the symptoms of schizophrenia in adults. The placebo used in this study was a nutritional substance known as 20% Intralipid emulsion given to patients requiring intravenous feedings.
NCT00077714 Trial Evaluating the Efficacy and Safety of 2 Fixed Doses of Paliperidone Extended-Release (ER) Tablets in the Treatment of Adult Patients With Schizophrenia Completed Johnson & Johnson Pharmaceutical Research & Development, L.L.C. Phase 3 The purpose of this trial is to determine if paliperidone ER is an effective treatment for adults with schizophrenia.
NCT00078039 Trial Evaluating Three Fixed Dosages of Paliperidone Extended-Release (ER) Tablets and Olanzapine in the Treatment of Patients With Schizophrenia Completed Johnson & Johnson Pharmaceutical Research & Development, L.L.C. Phase 3 The primary objective of the double blind phase of this study is to evaluate the efficacy and safety of 3 fixed dosages of paliperidone ER (6, 9, and 12 mg/day) compared with placebo in adult patients with schizophrenia.
Trial ID Title Status Sponsor Phase Summary

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Clinical Trial Conditions for Paliperidone

Condition Name

Condition Name for Paliperidone
Intervention Trials
Schizophrenia 137
Schizoaffective Disorder 16
Bipolar Disorder 13
Psychotic Disorders 7
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Condition MeSH

Condition MeSH for Paliperidone
Intervention Trials
Schizophrenia 142
Psychotic Disorders 27
Disease 22
Mental Disorders 15
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Locations for Paliperidone

Trials by Country

Trials by Country for Paliperidone
Location Trials
United States 375
Korea, Republic of 28
China 22
Spain 21
Taiwan 17
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Trials by US State

Trials by US State for Paliperidone
Location Trials
California 32
Texas 28
Florida 23
Ohio 21
New York 20
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Progress for Paliperidone

Clinical Trial Phase

Clinical Trial Phase for Paliperidone
Clinical Trial Phase Trials
Phase 4 57
Phase 3 56
Phase 2/Phase 3 1
[disabled in preview] 14
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Status

Clinical Trial Status for Paliperidone
Clinical Trial Phase Trials
Completed 129
Recruiting 14
Terminated 8
[disabled in preview] 5
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Sponsors for Paliperidone

Sponsor Name

Sponsor Name for Paliperidone
Sponsor Trials
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 57
Janssen Research & Development, LLC 12
Janssen Korea, Ltd., Korea 10
[disabled in preview] 8
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Sponsor Type

Sponsor Type for Paliperidone
Sponsor Trials
Industry 151
Other 56
NIH 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

AstraZeneca
Colorcon
Chinese Patent Office
Cantor Fitzgerald
Cerilliant
Julphar
Baxter
Citi
US Department of Justice

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.